Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies

P H Barrett1, B M Bell, C Cobelli

  • 1Department of Bioengineering, University of Washington, Seattle 98195-2255, USA.

Metabolism: Clinical and Experimental
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal optimization of exercise to lower fasting glucose levels.

The Journal of physiology·2023
Same author

A new oral model of free fatty acid kinetics to assess lipolysis in subjects with and without type 2 diabetes.

American journal of physiology. Endocrinology and metabolism·2023
Same author

Effects of danofloxacin dosing regimen on gastrointestinal pharmacokinetics and fecal microbiome in steers.

Scientific reports·2021
Same author

Tracking the time course of reproduction number and lockdown's effect on human behaviour during SARS-CoV-2 epidemic: nonparametric estimation.

Scientific reports·2021
Same author

Comparison of oral, intravenous, and subcutaneous fluid therapy for resuscitation of calves with diarrhea.

Journal of dairy science·2019
Same author

Inducing remission of Type 2 diabetes in the Caribbean: findings from a mixed methods feasibility study of a low-calorie liquid diet-based intervention in Barbados.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same journal

Ablation of microglial estrogen receptor alpha predisposes male mice to diet-induced obesity.

Metabolism: clinical and experimental·2026
Same journal

Pathophysiology-based subtypes of individuals at high-risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes.

Metabolism: clinical and experimental·2026
Same journal

A thermosensitive TET-Parkin epigenetic axis couples mitochondrial quality control to adaptive thermogenesis in adipose tissue.

Metabolism: clinical and experimental·2026
Same journal

Raffinose targets the NQO1/NF-κB axis to attenuate DON-driven microglial activation and neuroinflammation via metabolic reprogramming.

Metabolism: clinical and experimental·2026
Same journal

Endothelial NPR-C promotes insulin resistance via Caveolin-1-mediated insulin transcytosis.

Metabolism: clinical and experimental·2026
Same journal

Macrophage-enriched GPR91 aggravates acute liver injury by inhibiting efferocytosis via the AC/cAMP/PPARγ pathway.

Metabolism: clinical and experimental·2026
See all related articles

This report introduces Simulation, Analysis, and Modeling Software II (SAAM II), a tool designed to aid researchers in kinetic analysis and experimental design for metabolic systems and drug disposition studies.

Area of Science:

  • Physiology
  • Pharmacokinetics
  • Systems Biology

Background:

  • Kinetic analysis and integrated systems modeling are crucial for understanding metabolic systems and drug distribution/clearance.
  • These techniques are increasingly recognized for their utility in experimental design.
  • Kinetic analysis requires specialized expertise, influencing experimental design and tool development.

Purpose of the Study:

  • To describe Simulation, Analysis, and Modeling Software II (SAAM II).
  • To illustrate the application of SAAM II in experimental design.
  • To showcase SAAM II's utility in complex biological systems.

Main Methods:

  • General description of SAAM II capabilities.
  • Application of SAAM II using multicompartmental models.

Related Experiment Videos

  • Case studies in lipoprotein (apolipoprotein B kinetics) and diabetes (glucose minimal model) research.

    • Main Results:

    • Demonstration of SAAM II's utility in analyzing complex kinetic data.
    • Successful application of SAAM II in modeling lipoprotein and glucose metabolism.
    • Highlighting the software's role in advancing experimental design in physiological research.

    Conclusions:

    • SAAM II is a valuable software tool for kinetic analysis and experimental design.
    • The software facilitates the study of metabolic systems and drug disposition.
    • SAAM II supports research in areas like apolipoprotein B kinetics and glucose metabolism.